**Core tip:** Minimally invasive fusion of the sacroiliac (SI) joint is a potential treatment for patients suffering with symptoms related to the SI joint. This study used finite element analysis to investigate how implant orientation, superior implant length, and implant number affect SI joint range of motion. The results of this study demonstrate that placement of 3 implants across the SI joint using a transarticular orientation with superior implant reaching the sacral midline resulted in the most stable construct.

INTRODUCTION
============

Minimally invasive fusion of the sacroiliac (SI) joint is a potential treatment for patients suffering with symptoms related to the SI joint. Although diagnosis of the primary pain generator in low back pain is challenging\[[@B1]\], proper diagnosis allows for the most effective treatment. Of patients dealing with low back pain, between 15% and 30% have the SI joint as a pain generator\[[@B2]-[@B4]\].

Recently, minimally invasive fusion of the SI joint has been shown to be an effective method for reducing SI joint pain\[[@B5]\]. In addition, minimally invasive procedures have been shown to reduce blood loss, length of stay, and surgical time, while resulting in more positive outcomes for the patient compared with traditional open fusion procedures\[[@B5]\].

There are many factors that influence the choice and placement of implants placed across the SI joint. The sacral anatomy allows for placement of iliosacral hardware within sacral safe zones, although differences in anatomy have a significant effect on the location and size of the safe zones\[[@B6]\]. There is evidence that placement of multiple implants in unstable pelvic fracture models results in the greatest biomechanical stability\[[@B7]-[@B9]\]. Additional studies have demonstrated that placement of iliosacral screws within regions of higher bone density result in higher extraction forces\[[@B10],[@B11]\].

Previous *ex vivo* experimental studies have investigated the biomechanical effects of placing SI joint fusion devices\[[@B12],[@B13]\]. These studies have shown that placement of 3 triangular titanium plasma spray (TPS) coated titanium implants significantly reduced motion of the treated SI joint. A comparison of two lateral placement variations, inline (posterior) and transarticular, showed that both variations significantly reduced motion, and suggested that the transarticular orientation may provide more initial stability.

Finite element modeling is another technique used to investigate the biomechanics of the SI joint and pelvis\[[@B14]-[@B17]\]. Ivanov et al\[[@B14],[@B15]\] validated an SI joint FE model by comparing the FEA model ROM with experimental data for the intact and sequential ligament sectioning conditions from Simonian et al\[[@B18]\]. This SI joint model was later confirmed\[[@B17]\] to demonstrate that SI joint treatment using implants resulted in comparable reductions in motion to those reported in cadavers by Soriano-Baron et al\[[@B13]\].

Although, clinical and experimental evidence shows that placing 3 triangular TPS coated implants has successful clinical and biomechanical results, questions remain concerning the optimal parameters for implant placement. The objective of this study was to investigate and quantify the effect of implant orientation, superior implant length, and implant number on SI joint range of motion.

MATERIALS AND METHODS
=====================

A finite element model of the lumbar spine, pelvis, and both femurs was used to simulate SI joint motion; this model has previously been used to evaluate the effects of leg length discrepancy, effects of lumbar spine fusion on the SI joint, and effects of SI joint fusion on the lumbar spine\[[@B14]-[@B17]\]. The femoral head was fixed into the acetabular cup to ensure loading, but that no motion occurred at the hip joint. Briefly, a pelvis was scanned using computed tomography (CT) and material properties for bones, ligaments, and joints were assigned\[[@B14],[@B15]\]. The material properties of the sacral cancellous bone were assumed to be isotropic and varied in accordance to the apparent bone mineral density from a normal sacrum (*t*-score \> -1)\[[@B19]\] using a power law distribution (α = 2)\[[@B20]\]. For treated models, the core of the titanium plasma spray (TPS) coated implants (iFuse Implant 7.0 mm; SI-BONE, Inc., San Jose, CA, United States) was assigned the material properties of Ti6Al4V ELI (E = 115 GPa), the interface between the implant core and adjacent bone can be found in Lindsey et al\[[@B17]\].

Loading conditions/outcomes
---------------------------

The intact and instrumented model loads were simulated using a compressive follower load of 400 N, and a 10 N-m bending moment applied at the superior surface of the L1 vertebra\[[@B21],[@B22]\]. The compressive follower load was extended to the sacrum level and the angle of the connector elements defined such that the entire lumbo-pelvic segment did not go into any rotational motion following contraction of the connector elements. Loading was simulated in flexion-extension, lateral bending (left and right), and axial rotation (left and right) during double-leg stance. The range of motion of the SI joint was determined for each loading direction\[[@B14]\].

Treatment groups
----------------

Three treatment variables were investigated: Implant orientation, superior implant length, and implant number. Two potential implant orientations, inline (posterior) and transarticular, have been previously investigated\[[@B13]\] and both were further investigated here (Figure [1](#F1){ref-type="fig"}). Clinically, the superior implant length is often chosen to end within the middle of the ala (*i.e*., directly above the S1 foramen); based upon previous trauma literature\[[@B11]\], we also investigated a longer superior implant that extended to the midline of the sacrum (Figure [1](#F1){ref-type="fig"}). Typically, three implants are placed\[[@B23]\], for this investigation either 1, 2, or 3 implants were placed. All potential instrumented combinations were simulated, resulting in 22 unique models (Table [1](#T1){ref-type="table"}). The superior implant was either 55 mm long (mid-ala) or 75 mm long (mid-sacrum) for both the inline and transarticular orientation (placement of the superior implant is identical for the two orientations). The middle implants were 45 mm long for both the inline and transarticular orientations, while the inferior implant was 45 mm long for the inline orientation and 50 mm long for the transarticular orientation.

###### 

Sacroiliac joint range of motion for an intact model and 22 configurations of implant orientation, superior implant length, and number of implants

  **Treatment/orientation**    **Implant placed**   **Superior implant ending point**   **SI joint ROM (°) \[Reduction in ROM (%)\]**                                                                    
  ---------------------------- -------------------- ----------------------------------- ----------------------------------------------- ------------------------------------ ------------- ------------- -------------
  Intact                       \-                   \-                                  \-                                              \-[1](#T1FN1){ref-type="table-fn"}   1.94° (-)     0.66° (-)     1.11° (-)
  Inline orientation           X                    X                                   X                                               Mid-ala                              0.7° (64%)    0.45° (32%)   0.41° (63%)
  Mid-sacrum                   0.63° (68%)          0.41° (38%)                         0.38° (66%)                                                                                                      
  X                            \-                   X                                   Mid-ala                                         0.82° (58%)                          0.47° (29%)   0.44° (60%)   
  Mid-sacrum                   0.69° (64%)          0.43° (35%)                         0.4° (64%)                                                                                                       
  X                            X                    \-                                  Mid-ala                                         0.97° (50%)                          0.5° (24%)    0.49° (56%)   
  Mid-sacrum                   0.76° (61%)          0.45° (32%)                         0.43° (61%)                                                                                                      
  \-                           X                    X                                   \-[1](#T1FN1){ref-type="table-fn"}              0.91° (53%)                          0.53° (20%)   0.55° (50%)   
  X                            \-                   \-                                  Mid-ala                                         1.36° (30%)                          0.58° (12%)   0.67° (40%)   
  Mid-sacrum                   1.21° (38%)          0.58° (12%)                         0.61° (45%)                                                                                                      
  \-                           X                    \-                                  \-[1](#T1FN1){ref-type="table-fn"}              1.32° (32%)                          0.65° (2%)    0.73° (34%)   
  \-                           \-                   X                                   \-[1](#T1FN1){ref-type="table-fn"}              1.25° (36%)                          0.69° (-5%)   0.79° (29%)   
  Transarticular orientation   X                    X                                   X                                               Mid-ala                              0.59° (70%)   0.41° (38%)   0.34° (69%)
  Mid-sacrum                   0.52° (73%)          0.38° (42%)                         0.31° (72%)                                                                                                      
  X                            \-                   X                                   Mid-ala                                         0.69° (64%)                          0.42° (36%)   0.36° (68%)   
  Mid-sacrum                   0.58° (70%)          0.39° (41%)                         0.32° (71%)                                                                                                      
  X                            X                    \-                                  Mid-ala                                         0.81° (58%)                          0.45° (32%)   0.4° (64%)    
  Mid-sacrum                   0.64° (67%)          0.41° (38%)                         0.35° (68%)                                                                                                      
  \-                           X                    X                                   \-[1](#T1FN1){ref-type="table-fn"}              0.76° (61%)                          0.47° (29%)   0.46° (59%)   
  X                            \-                   \-                                  Mid-ala                                         1.36° (30%)                          0.58° (12%)   0.67° (40%)   
  Mid-sacrum                   1.21° (38%)          0.58° (12%)                         0.61° (45%)                                                                                                      
  \-                           X                    \-                                  \-[1](#T1FN1){ref-type="table-fn"}              1.11° (43%)                          0.6° (9%)     0.7° (37%)    
  \-                           \-                   X                                   \-[1](#T1FN1){ref-type="table-fn"}              1.05° (46%)                          0.62° (6%)    0.73° (34%)   

Configuration does not include a superior implant. SI: Sacroiliac; ROM: Range of motion.

![Finite element models tested in this study used either an inline or transarticular orientation. For models that included a superior implant, the length was varied such that the implant ended above the S1 foramen (mid-ala) or the midline of the sacrum (mid-sacrum).](WJO-9-14-g001){#F1}

Statistical analysis
--------------------

The effect of treatment was assessed by calculating the difference in ROM between the intact and treated configurations for each combination of implant orientation, superior implant length, and number of implants in flexion-extension, lateral bending, and axial rotation. The percent change was calculated in comparison with the intact ROM. The median and range for the difference in ROM and percent change were determined for each motion. Effects of individual treatment variables are described below.

**Implant orientation:** The effect of implant orientation was assessed by calculating the difference between the inline and transarticular (TA) configurations. Differences in ROM were calculated as a function of superior implant length (SIL) (mid-ala, mid-sacrum, or none) and number of implants (3-superior/middle/inferior, 2- superior/inferior, 2-superior/middle, 2-middle/inferior, 1-middle, and 1-inferior), for a total of 9 combinations. The percent change was calculated in comparison with the inline ROM. The treatment of one implant in the superior position was not compared between orientations since the configurations are identical for the inline and transarticular orientations. The median and range for the difference in ROM and percent change were determined.

**Superior implant length:** The effect of the superior implant length was assessed by calculating the difference between the mid-sacrum (MS) and mid-ala (MA) configurations. Differences in ROM were calculated as a function of orientation (Inline, Transarticular) and number of implants (3-superior/middle/inferior, 2-superior/inferior, 2-superior/middle, and 1-superior), for a total of 8 combinations. The percent change was calculated in comparison with the ROM of mid-ala superior implant length. The median and range for the difference in ROM and percent change were determined.

**Implant number:** The effect of implant number was assessed by calculating the difference in ROM between all single or dual implant configurations and the corresponding 3 implant configuration as a function of orientation (Inline, Transarticular) and superior implant length (SIL) (mid-ala, mid-sacrum) for a total of 18 combinations, and normalizing by the corresponding 3 implant configuration (implants without a superior implant were normalized to the mid-ala configuration). The median and range for the difference in ROM and percent change were determined for each single or dual implant configuration.

Animal care and use statement
-----------------------------

The article does not contain any studies with human participants or animals performed by any of the authors.

RESULTS
=======

Placement of 3 implants using the inline and transarticular orientations resulted in reductions in motion of 64%, 32%, 63%, and 70%, 38%, 69%, in flexion-extension, lateral bending, and axial rotation, respectively (Table [1](#T1){ref-type="table"}). These reductions are consistent with the range of reductions reported by Soriano-Baron et al\[[@B13]\] and provided confidence that this FE model is sufficient to make comparisons between treatment variables that have not previously been investigated in cadaver studies (*i.e*., implant number, placement technique, and superior implant length).

Transarticular placement of 3 implants with a mid-sacrum length superior implant resulted in the greatest reduction in range of motion (Table [1](#T1){ref-type="table"}). One superior implant (mid-ala length) has the least reduction in range of motion in flexion-extension; one inferior implant placed using the inline orientation has the least reduction in range of motion in lateral bending and axial rotation. Transarticular placement of a superior (mid-sacrum length) and inferior implant has the most reduction in range of motion for a 2 implant configuration.

Altering the implant orientation from the inline to the transarticular placement technique resulted in median reductions in motion of 16%, 9% and 18%, in flexion-extension, lateral bending, and axial rotation, respectively (Table [2](#T2){ref-type="table"}).

###### 

Reduction in sacroiliac joint range of motion (°) between transarticular and inline orientation groups

  **Orientation**              **Implants (positions)**             **Superior implant ending point**   **Reduction in SI joint ROM (°) (%)**                           
  ---------------------------- ------------------------------------ ----------------------------------- --------------------------------------- ----------------------- -------------
  Transarticular *vs* inline   3 (S, M, I)                          Mid-ala                             0.11° (16%)                             0.04° (9%)              0.07° (17%)
  Mid-sacrum                   0.11° (17%)                          0.03° (7%)                          0.07° (18%)                                                     
  2 (S, -, I)                  Mid-ala                              0.13° (16%)                         0.05° (11%)                             0.08° (18%)             
  Mid-sacrum                   0.11° (16%)                          0.04° (9%)                          0.08° (20%)                                                     
  2 (S, M, -)                  Mid-ala                              0.16° (16%)                         0.05° (10%)                             0.09° (18%)             
  Mid-sacrum                   0.12° (16%)                          0.04° (9%)                          0.08° (19%)                                                     
  2 (-, M, I)                  \-[1](#T2FN1){ref-type="table-fn"}   0.15° (16%)                         0.06° (11%)                             0.09° (16%)             
  1 (-, M, -)                  \-[1](#T2FN1){ref-type="table-fn"}   0.21° (16%)                         0.05° (8%)                              0.03° (4%)              
  1 (-, -, I)                  \-[1](#T2FN1){ref-type="table-fn"}   0.20° (16%)                         0.07° (10%)                             0.06° (8%)              
                               **Median (°) (Range)**               **0.13° (0.11-0.21**)               **0.05° (0.03-0.07)**                   **0.08° (0.03-0.09)**   
                               **Median (%) (Range)**               **16% (16-17)**                     **9% (7-11)**                           **18% (4-20)**          

Configuration does not include a superior implant. S: Superior; M: Middle; I: Inferior.

Extending the superior implant to the midline of the sacrum resulted in median reductions in motion of 14%, 8% and 9%, in flexion-extension, lateral bending, and axial rotation, respectively (Table [3](#T3){ref-type="table"}).

###### 

Reduction in sacroiliac joint range of motion (°) between mid-sacrum and mid-ala placement groups

                                                                             **Reduction in SI joint ROM (°) (%)**                            
  ------------------------- ------------------------ ----------------------- --------------------------------------- ------------------------ ------------
  Mid-sacrum *vs* mid-ala   Inline                   3 (S, M, I)             0.07° (10%)                             0.04° (9%)               0.03° (7%)
  2 (S, -, I)               0.13° (16%)              0.04° (9%)              0.04° (9%)                                                       
  2 (S, M, -)               0.21° (22%)              0.05° (10%)             0.06° (12%)                                                      
  1 (S, -, -)               0.15° (11%)              0.00° (0%)              0.06° (9%)                                                       
  Trans-articular           3 (S, M, I)              0.07° (12%)             0.03° (7%)                              0.03° (9%)               
  2 (S, -, I)               0.11° (16%)              0.03° (7%)              0.04° (11%)                                                      
  2 (S, M, -)               0.17° (21%)              0.04° (9%)              0.05° (13%)                                                      
  1 (S, -, -)               0.15° (11%)              0.00° (0%)              0.06° (9%)                                                       
                            **Median (°) (Range)**   **0.14° (0.07-0.21)**   **0.035° (0.00-0.05)**                  **0.045° (0.03-0.06)**   
                            **Median (%) (Range)**   **14% (10-22)**         **8% (0-10)**                           **9% (7-13)**            

The reduction in range of motion (%) was calculated in comparison to the to the mid-ala superior implant length. S: Superior; M: Middle; I: Inferior.

The two implant models with superior and inferior implants resulted in increased motions of 10%-17%, 2%-5% and 3%-7% compared with the 3 implant model, in flexion-extension, lateral bending, and axial rotation, respectively (Figure [2](#F2){ref-type="fig"}). Two implant models configurations with the implants placed close together (superior/middle, and middle/inferior) resulted in increased motions when compared with the 3 implant configuration of 21%-39%, 8%-18%, and 13%-35% in flexion-extension, lateral bending, and axial rotation, respectively (Figure [2](#F2){ref-type="fig"}; Tables [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}). For single implant models, the motion increases ranged from 78% to 133%, 29% to 53% and 61% to 115%, in flexion-extension, lateral bending, and axial rotation, respectively (Figure [2](#F2){ref-type="fig"}).

![Motion increase (%) for configurations with a reduced number of implants. The increase for each condition was normalized by the corresponding model that contained 3 implants. Note that a smaller increase in motion represents more reduction in range of motion. S: Superior; M: Middle; I: Inferior. Data is shown as median ± range.](WJO-9-14-g002){#F2}

###### 

Change in sacroiliac joint flexion-extension range of motion (°) as a result of reducing the number of implants

  **Treatment**    **Implants (positions)**   **Superior implant ending point**    **Range of motion (°)**   **Motion increase (°)**    **% 3 Implant motion**
  ---------------- -------------------------- ------------------------------------ ------------------------- -------------------------- --------------------------
  Intact           \-                         \-[1](#T4FN1){ref-type="table-fn"}   1.94                      \-                         \-
  Inline           3 (S, M, I)                Mid-ala                              0.7                       Reference configuration    
  Inline           2 (S, M, -)                Mid-ala                              0.97                      0.27                       39
  Inline           2 (S, -, I)                Mid-ala                              0.82                      0.12                       17
  Inline           2 (-, M, I)                \-[1](#T4FN1){ref-type="table-fn"}   0.91                      0.21                       30
  Inline           1 (S, -, -)                Mid-ala                              1.36                      0.66                       94
  Inline           1 (-, M, -)                \-[1](#T4FN1){ref-type="table-fn"}   1.32                      0.62                       89
  Inline           1 (-, -, I)                \-[1](#T4FN1){ref-type="table-fn"}   1.25                      0.55                       79
  Inline           3 (S, M, I)                Mid-sacrum                           0.63                      Reference configuration    
  Inline           2 (S, M, -)                Mid-sacrum                           0.76                      0.13                       21
  Inline           2 (S, -, I)                Mid-sacrum                           0.69                      0.06                       10
  Inline           1 (S, -, -)                Mid-sacrum                           1.21                      0.58                       92
  Transarticular   3 (S, M, I)                Mid-ala                              0.59                      Reference configuration    
  Transarticular   2 (S, M, -)                Mid-ala                              0.81                      0.22                       37
  Transarticular   2 (S, -, I)                Mid-ala                              0.69                      0.1                        17
  Transarticular   2 (-, M, I)                \-[1](#T4FN1){ref-type="table-fn"}   0.76                      0.17                       29
  Transarticular   1 (S, -, -)                Mid-ala                              1.36                      0.77                       131
  Transarticular   1 (-, M, -)                \-[1](#T4FN1){ref-type="table-fn"}   1.11                      0.52                       88
  Transarticular   1 (-, -, I)                \-[1](#T4FN1){ref-type="table-fn"}   1.05                      0.46                       78
  Transarticular   3 (S, M, I)                Mid-sacrum                           0.52                      Reference configuration    
  Transarticular   2 (S, M, -)                Mid-sacrum                           0.64                      0.12                       23
  Transarticular   2 (S, -, I)                Mid-sacrum                           0.58                      0.06                       12
  Transarticular   1 (S, -, -)                Mid-sacrum                           1.21                      0.69                       133
  **Treatment**    **Implants (positions)**   **Superior implant ending point**    **% 3 Implant motion**    **Implants (positions)**   **Median (%) \[range\]**
  Inline           2 (S, -, I)                Mid-ala                              17                        2 (S, -, I)                14.5% (10-17)
  Inline           2 (S, -, I)                Mid-sacrum                           10                                                   
  Transarticular   2 (S, -, I)                Mid-ala                              17                                                   
  Transarticular   2 (S, -, I)                Mid-sacrum                           12                                                   
  Inline           2 (S, M, -)                Mid-ala                              39                        2 (S, M, -)                30% (21-39)
  Inline           2 (S, M, -)                Mid-sacrum                           21                                                   
  Transarticular   2 (S, M, -)                Mid-ala                              37                                                   
  Transarticular   2 (S, M, -)                Mid-sacrum                           23                                                   
  Inline           2 (-, M, I)                \-[1](#T4FN1){ref-type="table-fn"}   30                        2 (-, M, I)                29.5% (29-30)
  Transarticular   2 (-, M, I)                \-[1](#T4FN1){ref-type="table-fn"}   29                                                   
  Inline           1 (S, -, -)                Mid-ala                              94                        1 (S, -, -)                112.5% (92-133)
  Inline           1 (S, -, -)                Mid-sacrum                           92                                                   
  Transarticular   1 (S, -, -)                Mid-ala                              131                                                  
  Transarticular   1 (S, -, -)                Mid-sacrum                           133                                                  
  Inline           1 (-, M, -)                \-[1](#T4FN1){ref-type="table-fn"}   89                        1 (-, M, -)                88.5% (88-89)
  Transarticular   1 (-, M, -)                \-[1](#T4FN1){ref-type="table-fn"}   88                                                   
  Inline           1 (-, -, I)                \-[1](#T4FN1){ref-type="table-fn"}   79                        1 (-, -, I)                78.5% (78-79)
  Transarticular   1 (-, -, I)                \-[1](#T4FN1){ref-type="table-fn"}   78                                                   

Configuration does not include a superior implant. S: Superior; M: Middle; I: Inferior.

###### 

Change in sacroiliac joint lateral bending range of motion (°) as a result of reducing the number of implants

  **Treatment**    **Implants (positions)**   **Superior implant ending point**    **Range of motion (°)**   **Motion increase (°)**    **% 3 implant motion**
  ---------------- -------------------------- ------------------------------------ ------------------------- -------------------------- --------------------------
  Intact           \-                         \-[1](#T5FN1){ref-type="table-fn"}   0.66                      \-                         \-
  Inline           3 (S, M, I)                Mid-ala                              0.45                      Reference configuration    
  Inline           2 (S, M, -)                Mid-ala                              0.5                       0.05                       11
  Inline           2 (S, -, I)                Mid-ala                              0.47                      0.02                       4
  Inline           2 (-, M, I)                \-[1](#T5FN1){ref-type="table-fn"}   0.53                      0.08                       18
  Inline           1 (S, -, -)                Mid-ala                              0.58                      0.13                       29
  Inline           1 (-, M, -)                \-[1](#T5FN1){ref-type="table-fn"}   0.65                      0.2                        44
  Inline           1 (-, -, I)                \-[1](#T5FN1){ref-type="table-fn"}   0.69                      0.24                       53
  Inline           3 (S, M, I)                Mid-sacrum                           0.41                      Reference configuration    
  Inline           2 (S, M, -)                Mid-sacrum                           0.45                      0.04                       10
  Inline           2 (S, -, I)                Mid-sacrum                           0.43                      0.02                       5
  Inline           1 (S, -, -)                Mid-sacrum                           0.58                      0.17                       41
  Transarticular   3 (S, M, I)                Mid-ala                              0.41                      Reference configuration    
  Transarticular   2 (S, M, -)                Mid-ala                              0.45                      0.04                       10
  Transarticular   2 (S, -, I)                Mid-ala                              0.42                      0.01                       2
  Transarticular   2 (-, M, I)                \-[1](#T5FN1){ref-type="table-fn"}   0.47                      0.06                       15
  Transarticular   1 (S, -, -)                Mid-ala                              0.58                      0.17                       41
  Transarticular   1 (-, M, -)                \-[1](#T5FN1){ref-type="table-fn"}   0.6                       0.19                       46
  Transarticular   1 (-, -, I)                \-[1](#T5FN1){ref-type="table-fn"}   0.62                      0.21                       51
  Transarticular   3 (S, M, I)                Mid-sacrum                           0.38                      Reference configuration    
  Transarticular   2 (S, M, -)                Mid-sacrum                           0.41                      0.03                       8
  Transarticular   2 (S, -, I)                Mid-sacrum                           0.39                      0.01                       3
  Transarticular   1 (S, -, -)                Mid-sacrum                           0.58                      0.2                        53
  **Treatment**    **Implants (positions)**   **Superior implant ending point**    **% 3 Implant motion**    **Implants (positions)**   **Median (%) \[range\]**
  Inline           2 (S, -, I)                Mid-ala                              4                         2 (S, -, I)                3.5% (2-5)
  Inline           2 (S, -, I)                Mid-sacrum                           5                                                    
  Transarticular   2 (S, -, I)                Mid-ala                              2                                                    
  Transarticular   2 (S, -, I)                Mid-sacrum                           3                                                    
  Inline           2 (S, M, -)                Mid-ala                              11                        2 (S, M, -)                10% (8-11)
  Inline           2 (S, M, -)                Mid-sacrum                           10                                                   
  Transarticular   2 (S, M, -)                Mid-ala                              10                                                   
  Transarticular   2 (S, M, -)                Mid-sacrum                           8                                                    
  Inline           2 (-, M, I)                \-[1](#T5FN1){ref-type="table-fn"}   18                        2 (-, M, I)                16.5% (15-18)
  Transarticular   2 (-, M, I)                \-[1](#T5FN1){ref-type="table-fn"}   15                                                   
  Inline           1 (S, -, -)                Mid-ala                              29                        1 (S, -, -)                41% (29-53)
  Inline           1 (S, -, -)                Mid-sacrum                           41                                                   
  Transarticular   1 (S, -, -)                Mid-ala                              41                                                   
  Transarticular   1 (S, -, -)                Mid-sacrum                           53                                                   
  Inline           1 (-, M, -)                \-[1](#T5FN1){ref-type="table-fn"}   44                        1 (-, M, -)                45% (44-46)
  Transarticular   1 (-, M, -)                \-[1](#T5FN1){ref-type="table-fn"}   46                                                   
  Inline           1 (-, -, I)                \-[1](#T5FN1){ref-type="table-fn"}   53                        1 (-, -, I)                52% (51-53)
  Transarticular   1 (-, -, I)                \-[1](#T5FN1){ref-type="table-fn"}   51                                                   

Configuration does not include a superior implant. S: Superior; M: Middle; I: Inferior.

###### 

Change in sacroiliac joint axial rotation range of motion (°) as a result of reducing the number of implants

  **Treatment**    **Implants (positions)**   **Superior implant ending point**   **Range of motion**      **Motion increase (°)**    **% 3 implant motion**
  ---------------- -------------------------- ----------------------------------- ------------------------ -------------------------- --------------------------
  Intact           \-                         [1](#T6FN1){ref-type="table-fn"}    1.11                     \-                         \-
  Inline           3 (S, M, I)                Mid-ala                             0.41                     Reference configuration    
  Inline           2 (S, M, -)                Mid-ala                             0.49                     0.08                       20
  Inline           2 (S, -, I)                Mid-ala                             0.44                     0.03                       7
  Inline           2 (-, M, I)                [1](#T6FN1){ref-type="table-fn"}    0.55                     0.14                       34
  Inline           1 (S, -, -)                Mid-ala                             0.67                     0.26                       63
  Inline           1 (-, M, -)                [1](#T6FN1){ref-type="table-fn"}    0.73                     0.32                       78
  Inline           1 (-, -, I)                [1](#T6FN1){ref-type="table-fn"}    0.79                     0.38                       93
  Inline           3 (S, M, I)                Mid-sacrum                          0.38                     Reference configuration    
  Inline           2 (S, M, -)                Mid-sacrum                          0.43                     0.05                       13
  Inline           2 (S, -, I)                Mid-sacrum                          0.4                      0.02                       5
  Inline           1 (S, -, -)                Mid-sacrum                          0.61                     0.23                       61
  Transarticular   3 (S, M, I)                Mid-ala                             0.34                     Reference configuration    
  Transarticular   2 (S, M, -)                Mid-ala                             0.4                      0.06                       18
  Transarticular   2 (S, -, I)                Mid-ala                             0.36                     0.02                       6
  Transarticular   2 (-, M, I)                [1](#T6FN1){ref-type="table-fn"}    0.46                     0.12                       35
  Transarticular   1 (S, -, -)                Mid-ala                             0.67                     0.33                       97
  Transarticular   1 (-, M, -)                [1](#T6FN1){ref-type="table-fn"}    0.7                      0.36                       106
  Transarticular   1 (-, -, I)                [1](#T6FN1){ref-type="table-fn"}    0.73                     0.39                       115
  Transarticular   3 (S, M, I)                Mid-sacrum                          0.31                     Reference configuration    
  Transarticular   2 (S, M, -)                Mid-sacrum                          0.35                     0.04                       13
  Transarticular   2 (S, -, I)                Mid-sacrum                          0.32                     0.01                       3
  Transarticular   1 (S, -, -)                Mid-sacrum                          0.61                     0.3                        97
  **Treatment**    **Implants (positions)**   **Superior implant ending point**   **% 3 Implant motion**   **Implants (positions)**   **Median (%) \[range\]**
  Inline           2 (S, -, I)                Mid-ala                             7                        2 (S, -, I)                5.5% (3-7)
  Inline           2 (S, -, I)                Mid-sacrum                          5                                                   
  Transarticular   2 (S, -, I)                Mid-ala                             6                                                   
  Transarticular   2 (S, -, I)                Mid-sacrum                          3                                                   
  Inline           2 (S, M, -)                Mid-ala                             20                       2 (S, M, -)                15.5% (13-20)
  Inline           2 (S, M, -)                Mid-sacrum                          13                                                  
  Transarticular   2 (S, M, -)                Mid-ala                             18                                                  
  Transarticular   2 (S, M, -)                Mid-sacrum                          13                                                  
  Inline           2 (-, M, I)                [1](#T6FN1){ref-type="table-fn"}    34                       2 (-, M, I)                34.5% (34-35)
  Transarticular   2 (-, M, I)                [1](#T6FN1){ref-type="table-fn"}    35                                                  
  Inline           1 (S, -, -)                Mid-ala                             63                       1 (S, -, -)                80% (61-97)
  Inline           1 (S, -, -)                Mid-sacrum                          61                                                  
  Transarticular   1 (S, -, -)                Mid-ala                             97                                                  
  Transarticular   1 (S, -, -)                Mid-sacrum                          97                                                  
  Inline           1 (-, M, -)                [1](#T6FN1){ref-type="table-fn"}    78                       1 (-, M, -)                92% (78-106)
  Transarticular   1 (-, M, -)                [1](#T6FN1){ref-type="table-fn"}    106                                                 
  Inline           1 (-, -, I)                [1](#T6FN1){ref-type="table-fn"}    93                       1 (-, -, I)                104% (93-115)
  Transarticular   1 (-, -, I)                [1](#T6FN1){ref-type="table-fn"}    115                                                 

Configuration does not include a superior implant. S: Superior; M: Middle; I: Inferior.

DISCUSSION
==========

The finite element model used in this study resulted in intact and treated SI joint motions that are consistent with previous experimental studies\[[@B13]\]. The combination of the current results and the previous validations confirm that both the intact and treated models in this study are functioning in a physiologic manner.

The current study demonstrated that the implant orientations across the SI joint can alter the range of motion. The SI joint contains both cartilaginous and fibrocartilaginous portions, with the cartilaginous portion exhibiting greater subchondral sacral bone density\[[@B19]\]. The transarticular orientation positions the middle and inferior implants more ventrally (approximately 15°-20°) and across the cartilaginous portion of the SI joint (Figure [1](#F1){ref-type="fig"}). Soriano-Baron et al\[[@B13]\] reported that the transarticular orientation had larger average reduction in SI joint ROM, although this was not determined to be significant.

The current study also demonstrated that placement of a longer superior implant resulted in reduced SI joint range of motion. Kraemer et al\[[@B11]\] demonstrated that iliosacral screws had a higher pullout force when the threads were positioned in the sacral midbody compared with those positioned in the ala. The results from Kraemer et al\[[@B11]\] are consistent with later anatomical studies that have reported reduced bone mineral density within the ala\[[@B24]\]. The current study demonstrated that increasing the length of the superior implant to the higher density bone of the sacral midline reduces the range of motion of the SI joint in flexion-extension, lateral bending, and axial rotation. Clinically, anatomic constraints must be considered prior to placement of a longer first implant.

The current study also demonstrated that placement of 3 implants resulted in greater motion reduction than any combination of two implants. Multiple studies have demonstrated that the use of a single SI screw results in less stability when compared with 2 SI screws\[[@B7]-[@B9]\]. The current study investigated treatment with 1, 2, or 3 implants to evaluate the treated SI joint range of motion as a function of implant number. Clinically, a prospective randomized trial documented 3 implants being placed in 91% of cases; with the rest of the cases using either 2 implants (5% cases) or 4 implants (4% cases)\[[@B23]\]. Although a small portion of clinical cases used 4 implants, this condition was not investigated in this study as placement is highly dependent on the size of the sacrum. The results from the current study demonstrate that reducing the number of placed implants results in increased initial SI joint range of motion. Two implants with increased separation, however, are more stable than 2 implants placed close together.

The current study is not without limitations. As with all finite element models, certain assumptions must be made to model the system. As previously noted, the current model is based on a single patient and did not simulate SI joint dysfunction, therefore generalizing the results to the general patient population should be made with care\[[@B17]\]. The current study assumed sacral cancellous bone material properties based on those found in normal cancellous bone (*t*-score \> -1). Although the reported bone mineral densities are different in the normal, osteopenic, and osteoporotic sacra, the distribution of low and high density locations are consistent in all three cases\[[@B19],[@B24]\]; as such, we expect that the findings in the different bone quality groups will be consistent. The current model and previous experimental study had consistent intact ROM and motion reductions after treatment, but there are some differences for the loading conditions simulated in this study (double-leg stance, follower load, and larger applied moment). Although the loading conditions were different, the consistency in intact ROM suggested that these disparities were counteracting each (*e.g*., follower load and double-leg stance increase stability; higher applied moment increase ROM)\[[@B17]\], and demonstrated that the SI joint and treatment were being effectively modeled. Lastly, the theoretical model used in this study did not model all *in vivo* characteristics (*e.g*., biological healing response after surgery); as such, additional clinical studies may be required to confirm these results.

While the minimum biomechanical requirements for clinically successful fixation of the SI joint are currently unknown, the current study investigated 3 clinical implant placement parameters and compared the resulting SI joint reduction in range of motion with a baseline model. The baseline model investigated here (inline orientation, mid-ala superior implant length, 3 implants) is a common technique that has positive clinical outcomes\[[@B23]\]. The range of motion of the SI joint in the current study was assessed in 3 anatomical loading directions, of which flexion-extension demonstrated both the largest intact range of motion (1.94°) and, after treatment, overall reductions in motion (0.58°-1.42°). Lateral bending and axial rotation resulted in small median reductions in motion (\< 0.1°) when the variables were investigated, which may not be clinically significant by themselves. In contrast, flexion-extension was more sensitive to altering the variables with median reductions in motion \> 0.1°. Although the 3 motions investigated had varying sensitivity, they consistently (*i.e*., positively/negatively) altered the reductions in motion. These results demonstrate that in flexion-extension, when compared with the baseline model, placement of the implants in areas of thicker cortical bone (transarticular orientation) and higher bone density (longer superior implant) leads to similar median increased reductions in motion of 16% and 14%, respectively. This study suggests that a surgeon can optimize implant placement in 3 ways: (1) Longer superior implants; (2) transarticular placement; and (3) using 3 implants (and/or increasing implant separation). Although the long-term clinical outcomes from these placement variations is unknown, the current study provides clinicians with insight and rationale into determining optimal implant placement.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Minimally invasive fusion of the sacroiliac (SI) joint is a potential treatment for patients suffering with symptoms related to the SI joint. The use of a lateral procedure for SI joint fusion has been shown to be an effective method for reducing SI joint pain. Previous anatomical studies have demonstrated significant variability in sacral anatomy and the resultant location and size of safe zones for implant placement.

Research motivation
-------------------

A surgeon has options regarding the number of implants, length of implants, and their orientation; the optimal placement parameters for SI joint fixation are currently unknown. Quantification of the changes in SI joint motion as a result of varying the potential implant placement variables will provide a surgeon input when performing an SI joint fusion procedure.

Research objectives
-------------------

The objective of this study was to investigate and quantify the effect of implant orientation, superior implant length, and implant number on SI joint range of motion.

Research methods
----------------

This study used a previously validated finite element analysis to investigate how implant orientation, superior implant length, and implant number affect SI joint range of motion. Implant orientation was simulated using either an inline or a transarticular placement. The length of the superior implant was varied to end either in the middle of the ala or at the sacral midline. The number of implants was 1, 2, or 3 implants. The SI joint range of motion was calculated using a constant moment of 10 N-m with a follower load of 400 N in flexion-extension, lateral bending, and axial rotation. A total of 23 model configurations were tested and the difference in SI joint range of motion compared.

Research results
----------------

The use of a transarticular placement with a mid-sacrum length superior implant resulted in the greatest reduction in SI joint ROM. The use of transarticular placement resulted in median reductions in motion of 16%, 9%, and 18%, in flexion-extension, lateral bending, and axial rotation, respectively. Extending the superior implant to the sacral midline resulted in median reductions in motion of 14%, 8%, and 9%, in flexion-extension, lateral bending, and axial rotation, respectively. Reducing the number of implants (*i.e*., 1 or 2 implants) resulted in increased motions in all directions. Implant configurations with 2 implants placed farthest apart had the smallest increases.

Research conclusions
--------------------

This study demonstrates that the treated SI joint range of motion is affected by implant orientation, superior implant length, and implant number. These results show that the optimal placement investigated was 3 implants placed using a transarticular placement with a superior implant that reaches the sacral midline. This study suggests that a surgeon can optimize implant placement in 3 ways: (1) Longer superior implants; (2) transarticular placement; and (3) using 3 implants (and/or increasing implant separation).

Research perspectives
---------------------

The use of a finite element model to simulate the SI joint and treatment effects allows for investigation of many variables and provides valuable insight regarding how each variable effects SI joint stability. These results allow for more detailed investigation using either *in vitro* or *in vivo* studies.
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